Arkolith/Insider Trading/ENOB/Form 4

Sindlev Rene

Director, 10% OwnerEnochian Biosciences Inc (ENOB) · full profile →Form 4 · filed Jul 18, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 8, 2022Other(J)125K——0
Jun 8, 2022Other(J)128K——0

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001731122-22-001223) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML